A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
FIASP (Insulin Aspart) is a medication prescribed for people with type 1 or type 2 diabetes mellitus. FIASP is an insulin analog that helps to improve glycemic control.
Patients with diabetes mellitus either (1) do not produce enough insulin to meet their needs, or (2) their bodies are resistant to insulin. FIASP and other insulin products act like regular human insulin to lower blood glucose to healthy levels.
Inject FIASP under the skin one to three times per day as directed by the doctor. The doctor will determine the dose of FIASP based on blood sugar readings.
FIASP is a rapid-acting insulin. It should be taken immediately before a meal or within 20 minutes after starting the meal. FIASP works best when injected before the start of a meal, but unlike other rapid-acting insulins, it can be injected up to 20 minutes later if needed.
Rotate injection sites between the abdomen, upper arm, and thigh to reduce the risk of lipodystrophy.
Insulin Aspart is the active ingredient in FIASP.
Some medications can mask the signs and symptoms of low blood sugar (hypoglycemia). Tell your healthcare provider if you are taking any of the following:
The following medications can affect blood sugar in people with diabetes. Use caution if you take any of these:
It is essential to become familiar with the signs of hypoglycemia while taking insulin because it can be life-threatening. Some of the most common signs are:
Monitor blood sugar regularly while using insulin. Your doctor may ask you to monitor more frequently when you make any changes to the dose, diet, exercise, or medications.
Tell your doctor if you have a history of problems with the heart, kidneys, or liver.
FIASP FlexTouch and FIASP PenFill should never be shared between more than one patient.
Common adverse reactions to FIASP can include:
Fiasp [package insert] Plainsboro, NJ: Novo Nordisk; 2019.